Abstract:Background and objectives: Neuronal intranuclear inclusion body disease (NIID) is a neurodegenerative disease with highly heterogeneous clinical manifestations. The present study aimed to characterize clinical features and propose a classification system based on a large cohort of NIID in China. Methods: The Chinese NIID registry was launched from 2017, and participants' demographics and clinical features were recorded. Brain MRI, skin pathologies, and the number of GGC repeat expansions in the 5' untranslated region of the NOTCH2NLC gene were evaluated in all patients. Results: In total, 223 patients (64.6% female) were recruited; the mean (SD) onset age was 56.7 (10.3) years. The most common manifestations were cognitive impairment (78.5%) and autonomic dysfunction (70.9%), followed by episodic symptoms (51.1%), movement disorders (50.7%), and muscle weakness (25.6%). Imaging markers included hyperintensity signals along the corticomedullary junction on diffusion-weighted imaging (96.6%), white matter lesions (98.1%), paravermis (55.0%), and focal cortical lesions (10.1%). The median size of the expanded GGC repeats in these patients was 115 (range, 70-525), with 2 patients carrying >300 GGC repeats. A larger number of GGC repeats was associated with younger age at onset (r = -0.329, p < 0.0001). According to the proposed clinical classification based on the most prominent manifestations, the patients were designated into 5 distinct types: cognitive impairment-dominant type (34.1%, n = 76), episodic neurogenic event-dominant type (32.3%, n = 72), movement disorder-dominant type (17.5%, n = 39), autonomic dysfunction-dominant type (8.5%, n = 19), and neuromuscular disease-dominant type (7.6%, n = 17). Notably, 32.3% of the episodic neurogenic event-dominant type of NIID has characteristic focal cortical lesions on brain MRI presenting localized cortical edema or atrophy. The mean onset age of the neuromuscular disease-dominant type was 47.2 (17.6) years, younger than the other types (p < 0.001). There was no significant difference in the sizes of GGC repeats among the patients in the 5 types (p = 0.547, Kruskal-Wallis test). Discussion: This observational study of NIID establishes an overall picture of the disease regarding clinical, imaging, and genetic characteristics. The proposed clinical classification of NIID based on the most prominent manifestation divides patients into 5 types.

Genetic Origin of Sporadic Cases and RNA Toxicity in Neuronal Intranuclear Inclusion Disease

The role of NOTCH2NLC in Parkinson's disease: A clinical, neuroimaging, and pathological study

GGC Repeat Expansion in NOTCH2NLC Induces Dysfunction in Ribosome Biogenesis and Translation.

Expression of expanded GGC repeats within NOTCH2NLC causes behavioral deficits and neurodegeneration in a mouse model of neuronal intranuclear inclusion disease

NOTCH2NLC-related Repeat Expansion Disorders: an Expanding Group of Neurodegenerative Disorders

Neuronal Intranuclear Inclusion Disease Tremor-Dominant Subtype: A Mimicker of Essential Tremor

Long-read sequencing identified repeat expansions in the 5′UTR of the NOTCH2NLC gene from Chinese patients with neuronal intranuclear inclusion disease

The Clinical Characteristics of Neuronal Intranuclear Inclusion Disease and Its Relation with Inflammation

Current advances in neuronal intranuclear inclusion disease

Clinical features of NOTCH2NLC-related neuronal intranuclear inclusion disease

Translation of GGC Repeat Expansions into a Toxic Polyglycine Protein in NIID Defines a Novel Class of Human Genetic Disorders: the Polyg Diseases.

Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases

[Clinical and genetic analysis of a patient with Neuronal intranuclear inclusion body disease characterized by cortical enhancement in the posterior brain region]

Pathologic Changes in Neuronal Intranuclear Inclusion Disease Are Linked to Aberrant FUS Interaction under Hyperosmotic Stress

Microglia contribute to polyG-dependent neurodegeneration in neuronal intranuclear inclusion disease

Clinical and mechanism advances of neuronal intranuclear inclusion disease

A family with neuronal intranuclear inclusion disease with focal segmental glomerulosclerosis

GGC Repeat Expansion of NOTCH2NLC in Taiwanese Patients With Inherited Neuropathies

CGG Repeat Expansion in NOTCH2NLC Causes Mitochondrial Dysfunction and Progressive Neurodegeneration in Drosophila Model.

Neuronal intranuclear inclusion disease with subclinical peripheral neuropathy: A case report

Clinical Features and Classification of Neuronal Intranuclear Inclusion Disease